1. Home
  2. CCM vs TRIB Comparison

CCM vs TRIB Comparison

Compare CCM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

HOLD

Current Price

$4.00

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.65

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCM
TRIB
Founded
1997
1992
Country
China
Ireland
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
14.0M
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
CCM
TRIB
Price
$4.00
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7K
125.9K
Earning Date
05-08-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.51
Revenue Next Year
N/A
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.18
$0.50
52 Week High
$10.77
$3.44

Technical Indicators

Market Signals
Indicator
CCM
TRIB
Relative Strength Index (RSI) 56.17 45.37
Support Level $3.58 $0.64
Resistance Level $4.14 $0.80
Average True Range (ATR) 0.06 0.05
MACD 0.01 0.00
Stochastic Oscillator 68.63 39.20

Price Performance

Historical Comparison
CCM
TRIB

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: